Acurx Pharmaceuticals ACXP
NASDAQ ACXP
$1.15 +0.01 (+0.87%)
As of: Oct 21, 2026 · 10:08 AM EDT

Acurx Pharmaceuticals (ACXP) Other financing activities (2023 - 2024)

Updated

Analysis

Acurx Pharmaceuticals (ACXP) Other financing activities (2023 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,129.39 Bn 1,097.98 Bn 19.71 Bn
2 Johnson & Johnson 615.68 Bn 534.21 Bn 17.26 Bn
3 AbbVie 505.77 Bn 478.89 Bn 12.70 Bn
4 Merck 366.50 Bn 320.88 Bn 12.21 Bn
5 Novartis Ag 297.33 Bn 261.32 Bn 11.24 Bn
6 Astrazeneca 261.02 Bn 234.71 Bn 12.86 Bn
7 Amgen 235.47 Bn 190.87 Bn 7.24 Bn
8 Gilead Sciences 189.20 Bn 163.40 Bn 6.22 Bn
9 Pfizer 170.20 Bn 116.85 Bn 10.94 Bn
10 Acurx Pharmaceuticals 4.94 Mn -28.52 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -11,508.00
Sep 30, 2024 -51,455.00
Jun 30, 2024 -10,601.00
Mar 31, 2024 -135,741.00
Jun 30, 2023 -456,314.00
API Access

Acurx Pharmaceuticals Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=ACXP&period=max&api_key=YOUR_API_KEY